ODT
Odonate Therapeutics, Inc. Common Stock
Delisted
ODT was delisted on the 14th of January, 2022.
89 hedge funds and large institutions have $495M invested in Odonate Therapeutics, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 41 increasing their positions, 16 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
62% less capital invested
Capital invested by funds: $1.29B → $495M (-$800M)
Holders
89
Holding in Top 10
2
Calls
$4M
Puts
$1.83M
Top Buyers
| 1 | +$34.3M | |
| 2 | +$24.8M | |
| 3 | +$15.6M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$13.1M |
| 5 |
RI
RTW Investments
New York
|
+$6.96M |
Top Sellers
| 1 | -$14.7M | |
| 2 | -$14.1M | |
| 3 | -$10.6M | |
| 4 |
CTA
Carillon Tower Advisers
St. Petersburg,
Florida
|
-$9.05M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$8.17M |